Literature DB >> 6662168

Use of gamma distributed residence times in pharmacokinetics.

M Weiss.   

Abstract

Using a nonclassical statistically based pharmacokinetic concept, a theory is presented which can be applied to the analysis of concentration-time data fitted by power functions of time C = At-ae-bt, which is shown to be equivalent to the assumption of gamma distributed residence times of drugs. The shape and scale parameters a and b, respectively, are interpreted physiologically in terms of a recirculatory model. It is shown how the shape parameter a, which is only dependent on the coefficient of variation of residence times, is affected by the processes of drug distribution and elimination. The time course of the blood concentration following multiple doses and continuous infusion is predicted for gamma-like drug disposition curves. The assumption of gamma distributed disposition residence times is theoretically based on a random walk model of circulatory drug transport, and the conditions are investigated under which gamma curves can be empirically fitted to oral concentration-time data. The parameters of concentration-time profiles following solid dosage forms, for example, are explained by the means and coefficients of variation of the disposition residence time and dissolution time distribution, respectively. The advantages of this concept compared to the conventional method of fitting sums of exponentials to the data are described.

Mesh:

Substances:

Year:  1983        PMID: 6662168     DOI: 10.1007/bf00542361

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  [A simple statistical dosage metabolism law].

Authors:  F H DOST
Journal:  Klin Wochenschr       Date:  1958-07-15

2.  Rapid compartment- and model-independent estimation of times required to attain various fractions of steady-state plasma level during multiple dosing of drugs obeying superposition principle and having various absorption or infusion kinetics.

Authors:  W L Chiou
Journal:  J Pharm Sci       Date:  1979-12       Impact factor: 3.534

3.  Importance of tissue distribution in determining drug disposition curves.

Authors:  M Weiss
Journal:  J Theor Biol       Date:  1983-08-21       Impact factor: 2.691

4.  Definition of pharmacokinetic parameters: influence of the sampling site.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

5.  Modelling of initial distribution of drugs following intravenous bolus injection.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Hemodynamic influences upon the variance of disposition residence time distribution of drugs.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

7.  Linearization of dissolution rate curves by the Weibull distribution.

Authors:  F Langenbucher
Journal:  J Pharm Pharmacol       Date:  1972-12       Impact factor: 3.765

8.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

9.  Residence time and accumulation of drugs in the body.

Authors:  M Weiss
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-02

10.  [Reconstruction of dissolution profiles of microcapsulated formulations by the mean and variance of dissolution times (author's transl)].

Authors:  D Brockmeier
Journal:  Arzneimittelforschung       Date:  1981
View more
  27 in total

1.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Systems dynamics in clinical pharmacokinetics. An introduction.

Authors:  J M van Rossum; J E de Bie
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

Review 3.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

4.  Mean time parameters for generalized physiological flow models (semihomogeneous linear systems).

Authors:  D Verotta; L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1991-06

5.  Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.

Authors:  Justin J Wilkins; Radojka M Savic; Mats O Karlsson; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

6.  Application of the dispersion model for description of the outflow dilution profiles of noneliminated reference indicators in rat liver perfusion studies.

Authors:  A J Schwab; W Geng; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

7.  A novel extravascular input function for the assessment of drug absorption in bioavailability studies.

Authors:  M Weiss
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

8.  Empirical models for fitting of oral concentration time curves with and without an intravenous reference.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-01       Impact factor: 2.745

9.  Pharmacokinetic stochastic model with Weibull-distributed residence times of drug molecules in the body.

Authors:  V K Piotrovskii
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Gamma variate fits to pharmacokinetic data.

Authors:  M Pfeffer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jul-Sep       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.